NewswireToday - /newswire/ -
San Antonio, TX, United States, 2011/06/03 - BD (Becton, Dickinson and Company), a leading global medical technology company, today celebrated the grand opening of its new North American Professional Service Center in San Antonio, Texas. NYSE: BDX
The site currently employs 125 BD associates and is expected to bring a total of nearly 300 new jobs to the Alamo City when fully operational.
BD has established the facility to provide various services, including finance, procurement, human resources, supply chain and customer services for its North American operations. The establishment of the North American Professional Service Center is part of the Company’s global strategy to establish four professional services headquarters throughout the world.
“We are very pleased to be operating our new facility in San Antonio,” said Vince Forlenza, BD President and Chief Operating Officer. “We appreciate the strong support we received from the City of San Antonio and the Texas Enterprise Fund, which helped us decide to establish our facility here. BD looks forward to becoming a good neighbor and a valued corporate citizen in this community.”
“BD is a wonderful addition our city’s business community,” said San Antonio Mayor Julian Castro. “It is a leading global medical technology company recognized around the world for corporate responsibility, innovation, health and safety, and is an employer of choice. With nearly 300 employees planned for San Antonio and an annual payroll exceeding $12 million, BD is another great example of why the City and the San Antonio Economic Development Foundation work diligently to recruit industry leaders. We welcome BD as a great corporate citizen that shares our values and vision.”
In Texas, BD also employs 25 associates at its Austin facility and operates a field sales office in Coppell.
BD (bd.com) is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.